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1. Introduction 
The uptake into liver of [“Cl cY-aminoisobutyric 
acid (14C-AIB), an amino acid that is transported like 
naturally occurring neutral amino acids but is not 
metabolized, has been shown to be increased by 
glucagon [I]. This effect of glucagon. like others, 
appears to be mediated by cyclic AMP, indeed, 
dibutyryl cyclic AMP itself caused a similar effect [l] 
We were interested in knowing whether the entry of 
the amino acid into other tissues besides liver is 
influenced by glucagon or by dibutyryl cyclic AMP 
and consequently have studied in more detail the 
distribution of 14C-AIB in rats treated with these 
agents. 
2. Methods 
Male albino rats from the Wistar strain were 
obtained locally (Harlan Industries, Cumberland, 
Indiana). The rats were given 1-[‘4C] AIB (New 
England Nuclear Corporation, specific activity 
12.2 &i/flmol) by subcutaneous injection at a dose 
of 10 &i/kg 24 hr before they were killed. Food 
was withheld after [ 14C] AIB injection. Two hr 
before the rats were killed, they were given glucagon 
(Lilly) at a dose of 1 mg/kg S.C. or N6,U2-dibutyryl 
cyclic AMP (Sigma) at a dose of 50 mg/kg i.p. Rats 
were killed by cervical dislocation and all tissues 
were removed rapidly and frozen on dry ice. The 
tissues were stored frozen prior to analysis. They were 
then homogenized in 4 vol of 0.1 N HCl, and 1 vol 
of 30% prechloric acid was added to precipitate 
proteins. After centrifugation, aliquots of the super- 
8 
natant fluid were taken for liquid scintillation spec- 
trometry. 
Table 1 
Distribution of radioactivity in tissues of rats given 
[14C] a-aminoisobutyric acid 
Tissue Treatment group 
Control Glucagon Dibutyryl CAMP 
dpm/g (in thousands) 
Kidney 207 + 24 193 f 4 151 f 14* 
(93%) (73%) 
Liver 47 * 4 107 f 5* 78 f 3* 
(228%) (166%) 
Spleen 31 i 2 30* 2 33 ?: 3 
(97%) (106%) 
Heart 24 + 1 23 i: 2 26 f 2 
(96%) (108%) 
Brain 19+ 1 18 f 0.5 19+0.4, 
(95%) (100%) 
Skeletal muscle 17 f 0.5 14 * 0.7 16 f 0.6 
(8 2%) (94%) 
Lung 17 f 0.7 14+ 1 18 + 1 
(82%) (106%) 
Adrenal 15 f 1 13Y? 1 18 + 1 
(87%) (120%) 
Epididymal fat 9 f 0.8 6 f 0.3* 6 jl 0.3* 
(67%) (67%) 
Blood plasma 9 f 0.5 5 + 0.3* 7 f 0.3 
(56%) (78%) 
*Significantly different from control group P < 0.01. Numbers 
in parenthesis represent percent of control value for that 
tissue. 
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3. Results 
Table 1 lists the content of [14C] AIB in rat 
tissues in order of decreasing concentration. The 
enhancement of [’ 4 C] AIB uptake into liver as 
reported previously by Scott et al. [l] after glucagon 
or dibutyryl cyclic AMP injection is confirmed in 
our experiment. The ratio of liver/plasma concen- 
tration was 5 in control rats, 11 in rats treated with 
dibutyryl cyclic AMP, and 21 in rats treated with 
glucagon. Only the liver showed enhanced amino 
acid uptake. The concentration of radioactivity in 
epididymal fat paralleled exactly that in plasma, 
hence was decreased slightly but significantly in rats 
treated with glucagon or with dibutyryl cyclic AMP. 
The concentration of radioactivity in kidney was 
decreased significantly in dibutyryl cyclic AMP- 
treated rats. 
4. Discussion 
One objective in this study was to determine if 
the increase of amino acid uptake into liver was 
associated with a decreased amino acid concentration 
in a specific tissues. Glucagon did not cause a 
significant decrease in amino acid concentration in 
any tissue other than epididymal fat, a tissue with 
very low concentration of the amino acid. AIB levels 
in skeletal muscle and in lung tended to be decreased; 
considering the large mass of muscle tissue, one 
suspects that the small statistically insignificant 
decrease in AIB concentration in that tissue could 
well have supplied the amount of amino acid that 
caused the increase in liver concentration. Dibutyryl 
cyclic AMP injection caused a decrease in amino 
acid concentration in the kidney. 
The results suggest hat perhaps only the liver 
has a cyclic AMP-dependent amino acid uptake 
mechanism. The failure of glucagon to stimulate 
[14C] AIB into tissues other than liver could reflect 
a lack of glucagon-sensitive adenyl cyclase in most 
tissues. However, even dibutyryl cyclic AMP did not 
stimulate amino acid uptake into any other tissue, 
and a possible interpretation of this finding is that 
cyclic AMP does not mediate amino acid uptake in 
tissues other than liver. 
An alternative explanation for the elevation of 
hepatic AIB content besides the existence of a 
cyclic AMP-dependent amino acid uptake mechanism 
in liver could be enhanced blood flow to the liver. 
Glucagon is known to increase hepatic blood flow 
[2-41, and it would be unreasonable to think that 
dibutyryl cyclic AMP might have a similar action. 
However, Chambers et al. [5] have shown that 
glucagon stimulates AIB uptake in the isolated, 
perfused liver, hence the increase of AIB content in 
liver of glucagon-treated rats (table 1) is probably 
partly if not entirely due to stimulation of amino 
acid transport by glucagon. 
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